Each year, more than half a million women are diagnosed with cervical cancer and the
disease results in over 300 000 deaths worldwide. High-risk subtypes of the human …

Advanced-inoperable cervical cancer is a challenging entity due to increased percentage of
locoregional and distant recurrences. Furthermore, recurrent cervical cancer not amenable …

Cervical cancer is a malignant epithelial tumor that forms in the uterine cervix. Most cases of
cervical cancer are preventable through human papilloma virus (HPV) vaccination, routine …

Cervical cancer is the second most commonly diagnosed cancer and the third leading cause
of cancer death among females in less developed countries. There were an estimated 527 …

Purpose We compared the efficacy and toxicity of neoadjuvant chemotherapy followed by
radical surgery versus standard cisplatin-based chemoradiation in patients with locally …

Background Standard treatment for locally advanced cervical cancer is chemoradiotherapy,
but many patients relapse and die of metastatic disease. We aimed to determine the effects …

BACKGROUND: To analyse the overall clinical outcome and benefits by applying protocol
based image guided adaptive brachytherapy combined with 3D conformal external beam …

Concurrent cisplatin-based chemotherapy and radiotherapy (CCRT) plus brachytherapy is
standard treatment for locally advanced cervical cancer. Platinum-based neoadjuvant …

Cervical cancer is the third most common cancer in women, with an estimated 529828 new
cases and 275128 deaths reported worldwide in 2008. More than 85% of the global burden …

Purpose To provide evidence-based, resource-stratified global recommendations to
clinicians and policymakers on the management and palliative care of women diagnosed …